Catabasis Pharma (CATB)

Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus

Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference

Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference

2 Biotech Stocks Wall Street Predicts Will Rally By More Than 150%

The Biotech industry has been instrumental in developing treatments for the coronavirus. The sector’s long-term potential remains solid due to the aging populating and the rising cost of healthcare. Wall Street analysts expect biotech stocks Sorrento Therapeutics (SRNE) and Catabasis Pharmaceuticals (CATB) to deliver exponential returns in the upcoming months.

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences

Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update

First Week of CATB May 21st Options Trading

Investors in Catabasis Pharmaceuticals Inc (CATB) saw new options begin trading this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CATB options chain for the new May 21st contracts and identified one put and one call contract of particular interest.

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update

Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences